Begbies Traynor Group PLC
LSE:BEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Begbies Traynor Group PLC
LSE:BEG
|
UK |
|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
US |
|
Tifico Fiber Indonesia Tbk PT
IDX:TFCO
|
ID |
|
A
|
Avrupa Yatirim Holding AS
IST:AVHOL.E
|
TR |
Balance Sheet
Balance Sheet Decomposition
Begbies Traynor Group PLC
Begbies Traynor Group PLC
Balance Sheet
Begbies Traynor Group PLC
| Apr-2005 | Apr-2006 | Apr-2007 | Apr-2008 | Apr-2009 | Apr-2010 | Apr-2011 | Apr-2012 | Apr-2013 | Apr-2014 | Apr-2015 | Apr-2016 | Apr-2017 | Apr-2018 | Apr-2019 | Apr-2020 | Apr-2021 | Apr-2022 | Apr-2023 | Apr-2024 | Apr-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
1
|
0
|
3
|
4
|
4
|
5
|
8
|
9
|
8
|
7
|
4
|
4
|
7
|
8
|
10
|
8
|
6
|
8
|
|
| Cash |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
1
|
1
|
0
|
3
|
4
|
4
|
5
|
8
|
9
|
8
|
7
|
4
|
4
|
7
|
8
|
10
|
8
|
6
|
8
|
|
| Total Receivables |
13
|
20
|
25
|
30
|
40
|
47
|
43
|
44
|
40
|
37
|
35
|
35
|
30
|
29
|
32
|
37
|
45
|
50
|
56
|
64
|
70
|
|
| Accounts Receivables |
1
|
2
|
4
|
5
|
8
|
8
|
8
|
7
|
6
|
4
|
5
|
6
|
5
|
29
|
7
|
6
|
8
|
9
|
12
|
13
|
14
|
|
| Other Receivables |
12
|
18
|
21
|
25
|
33
|
39
|
35
|
37
|
34
|
33
|
30
|
28
|
25
|
0
|
26
|
31
|
37
|
41
|
44
|
51
|
56
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
14
|
21
|
25
|
31
|
41
|
50
|
57
|
48
|
45
|
44
|
44
|
42
|
37
|
32
|
36
|
44
|
53
|
59
|
64
|
69
|
78
|
|
| PP&E Net |
3
|
4
|
4
|
7
|
7
|
7
|
7
|
3
|
2
|
2
|
3
|
2
|
2
|
9
|
9
|
9
|
10
|
8
|
10
|
13
|
13
|
|
| PP&E Gross |
3
|
4
|
4
|
7
|
7
|
7
|
7
|
3
|
2
|
2
|
3
|
2
|
2
|
9
|
9
|
9
|
10
|
8
|
10
|
13
|
13
|
|
| Accumulated Depreciation |
2
|
3
|
4
|
3
|
4
|
5
|
7
|
5
|
6
|
7
|
7
|
7
|
7
|
13
|
16
|
17
|
19
|
22
|
25
|
29
|
30
|
|
| Intangible Assets |
0
|
0
|
1
|
2
|
1
|
1
|
2
|
2
|
1
|
2
|
9
|
8
|
8
|
9
|
9
|
9
|
18
|
15
|
13
|
9
|
6
|
|
| Goodwill |
27
|
37
|
42
|
49
|
53
|
52
|
49
|
49
|
49
|
49
|
49
|
50
|
50
|
50
|
50
|
50
|
60
|
60
|
60
|
63
|
63
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
5
|
4
|
4
|
5
|
3
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
27
|
37
|
42
|
49
|
53
|
52
|
49
|
49
|
49
|
49
|
49
|
50
|
50
|
50
|
50
|
50
|
60
|
60
|
60
|
63
|
63
|
|
| Total Assets |
43
N/A
|
62
+44%
|
72
+16%
|
89
+23%
|
101
+14%
|
110
+9%
|
115
+5%
|
102
-12%
|
98
-4%
|
97
0%
|
104
+7%
|
103
-2%
|
96
-6%
|
102
+6%
|
108
+6%
|
117
+8%
|
144
+24%
|
146
+1%
|
152
+4%
|
158
+4%
|
162
+3%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
4
|
5
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
2
|
1
|
16
|
1
|
1
|
1
|
2
|
2
|
52
|
54
|
|
| Accrued Liabilities |
1
|
2
|
8
|
9
|
8
|
9
|
11
|
8
|
8
|
7
|
7
|
8
|
7
|
0
|
10
|
11
|
11
|
14
|
16
|
17
|
20
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
1
|
1
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
3
|
2
|
2
|
2
|
3
|
|
| Other Current Liabilities |
1
|
3
|
4
|
5
|
4
|
4
|
4
|
3
|
3
|
2
|
4
|
8
|
7
|
2
|
14
|
13
|
23
|
25
|
27
|
31
|
32
|
|
| Total Current Liabilities |
11
|
11
|
14
|
17
|
19
|
17
|
19
|
13
|
12
|
10
|
13
|
18
|
15
|
21
|
26
|
27
|
39
|
42
|
46
|
53
|
57
|
|
| Long-Term Debt |
5
|
9
|
5
|
16
|
12
|
21
|
25
|
24
|
22
|
22
|
22
|
18
|
17
|
17
|
17
|
16
|
11
|
10
|
12
|
17
|
14
|
|
| Deferred Income Tax |
0
|
0
|
1
|
2
|
4
|
5
|
5
|
5
|
5
|
5
|
6
|
6
|
5
|
5
|
5
|
6
|
6
|
8
|
7
|
7
|
7
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
4
|
3
|
4
|
3
|
0
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
3
|
2
|
2
|
3
|
2
|
2
|
3
|
3
|
|
| Total Liabilities |
17
N/A
|
24
+43%
|
22
-6%
|
39
+77%
|
38
-4%
|
43
+14%
|
50
+15%
|
43
-13%
|
40
-8%
|
38
-5%
|
43
+14%
|
42
-3%
|
38
-9%
|
46
+19%
|
50
+10%
|
51
+2%
|
58
+14%
|
62
+7%
|
68
+9%
|
79
+18%
|
80
+1%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
3
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
8
|
8
|
8
|
8
|
8
|
|
| Retained Earnings |
23
|
22
|
24
|
23
|
25
|
28
|
44
|
36
|
36
|
37
|
33
|
32
|
29
|
29
|
30
|
30
|
49
|
47
|
47
|
43
|
44
|
|
| Additional Paid In Capital |
0
|
13
|
22
|
22
|
34
|
35
|
17
|
18
|
18
|
18
|
23
|
23
|
23
|
22
|
22
|
30
|
29
|
30
|
30
|
31
|
31
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
27
N/A
|
38
+45%
|
50
+30%
|
49
-1%
|
64
+29%
|
67
+5%
|
66
-2%
|
59
-11%
|
58
-1%
|
59
+3%
|
61
+3%
|
60
-1%
|
58
-3%
|
56
-3%
|
58
+3%
|
66
+13%
|
86
+32%
|
85
-2%
|
84
0%
|
78
-7%
|
82
+5%
|
|
| Total Liabilities & Equity |
43
N/A
|
62
+44%
|
72
+16%
|
89
+23%
|
101
+14%
|
110
+9%
|
115
+5%
|
102
-12%
|
98
-4%
|
97
0%
|
104
+7%
|
103
-2%
|
96
-6%
|
102
+6%
|
108
+6%
|
117
+8%
|
144
+24%
|
146
+1%
|
152
+4%
|
158
+4%
|
162
+3%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
65
|
75
|
81
|
81
|
89
|
90
|
90
|
90
|
93
|
98
|
110
|
111
|
107
|
110
|
114
|
128
|
151
|
153
|
155
|
159
|
160
|
|